The RNA Component of Human Telomerase
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Eukaryotic chromosomes are capped with repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex. Here, the cloning of the RNA component of human telomerase, termed hTR, is described. The template region of hTR encompasses 11 nucleotides (5′-CUAACCCUAAC) complementary to the human telomere sequence (TTAGGG) n . Germline tissues and tumor cell lines expressed more hTR than normal somatic cells and tissues, which have no detectable telomerase activity. Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity. HeLa cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings. Thus, human telomerase is a critical enzyme for the long-term proliferation of immortal tumor cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Key components of telomerase are telomerase reverse transcriptase (TERT) (88) and telomerase RNA (89).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [89]
In the citing paper
“expression of antisense RNA complementary to the human telomerase RNA component (hTR) caused decreased proliferation of HeLa cells after 23 to 26 doublings (24).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [24]
In the citing paper
“The shortening of telomeres occurs with each cell division, ultimately causing cells to reach their Hayflick limit, whereby growth stops after approximately 60 times population doubling [2,3,4,5].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“When telomeres become too short and cannot function naturally, cellular senescence in the M1 phase (a cellular growth arrest, also called the M1 stage) occurs [5,6,7].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“In human cells, the enzyme comprises a high molecular weight complex with a template-containing RNA subunit (Feng et al., 1995) and protein components including the catalytic subunit human telomerase reverse transcriptase, hTERT (Harrington et al., 1997;Meyerson et al., 1997;Nakamura et al., 1997).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Feng et al., 1995
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationTight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Self-citationTelomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Self-citationCounter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Self-citationOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citation
Research works printed but not linked: 7
- AUTEXIER, C, FUNCTIONAL RECONSTITUTION OF WILD-TYPE AND MUTANT TETRAHYMENA TELOMERASE, GENES & DEVELOPMENT 8: 563 (1994). · DOI
- AVILION A.A. THESIS STATE U NEW Y (1995).
- Broccoli, D., Proceedings of the National Academy of Sciences of the United States of America 92: 9082 (1995).
- CHADENEAU, C, ONCOGENE 11: 841 (1995).
- Hernandez, N., Transcriptional Regulation: 281 (1992).
- Muller, H. J., Collecting Net 13: 181 (1938).
- WATSON, J. D., NATURE-NEW BIOLOGY 239: 197 (1972).
Cited by
Items 101–200 of 1,004
Structure of the Tribolium castaneum telomerase catalytic subunit TERT
Gillis, A. J., Schuller, A. P., & Skordalakes, E. (2008) · Nature · doi:10.1038/nature07283 · Cited by 281
Human telomerase RNA and box H/ACA scaRNAs share a common Cajal body–specific localization signal
Jády, B. E., Bertrand, E., & Kiss, T. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200310138 · Cited by 274
“Because hTR is a pol II product (Feng et al., 1995), we tested whether it has a TMG cap.”
BackgroundThe biogenesis and regulation of telomerase holoenzymes
Collins, K. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1961 · Cited by 284
“Similarly, human telomerase RNPs accumulate ubiquitously in cells regardless of the presence of telomerase activity in cell extract”
BackgroundDifferential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis
Blasco, M. A., Rizen, M., Greider, C. W., & Hanahan, D. (1996) · Nature Genetics · doi:10.1038/ng0296-200 · Cited by 285
Self-citationWick, M., Zubov, D., & Hagen, G. (1999) · Gene · doi:10.1016/s0378-1119(99)00108-0 · Cited by 280
Oocyte polarity and cell determination in early mammalian embryos
Edwards, R. (1997) · Molecular Human Reproduction · doi:10.1093/molehr/3.10.863 · Cited by 289
Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)
Poole, J. C., Andrews, L. G., & Tollefsbol, T. O. (2001) · Gene · doi:10.1016/s0378-1119(01)00440-1 · Cited by 274
Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction
Elmore, L. W., Rehder, C. W., Di, X., McChesney, P. A., Jackson-Cook, C. K., Gewirtz, D. A., & Holt, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205477200 · Cited by 271
Telomerase: Structure, functions, and activity regulation
Zvereva, M. I., Shcherbakova, D. M., & Dontsova, O. A. (2010) · Biochemistry (Moscow) · doi:10.1134/s0006297910130055 · Cited by 165
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer
Leão, R., Apolónio, J. D., Lee, D., Figueiredo, A., Tabori, U., & Castelo-Branco, P. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0422-8 · Cited by 265
Telomere lengthening and telomerase activation during human B cell differentiation
Weng, N.-P., Granger, L., & Hodes, R. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10827 · Cited by 271
Subsenescent Telomere Lengths in Fibroblasts Immortalized by Limiting Amounts of Telomerase
Ouellette, M. M., Liao, M., Herbert, B.-S., Johnson, M., Holt, S. E., Liss, H. S., Shay, J. W., & Wright, W. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10072 · Cited by 271
Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets
Fatima, R., Akhade, V. S., Pal, D., & Rao, S. M. (2015) · Molecular and Cellular Therapies · doi:10.1186/s40591-015-0042-6 · Cited by 263
“[208].”
Telomere Length Is a Determinant of Emphysema Susceptibility
Alder, J. K., Guo, N., Kembou, F., Parry, E. M., Anderson, C. J., Gorgy, A. I., Walsh, M. F., Sussan, T., Biswal, S., Mitzner, W., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0520oc · Cited by 265
Telomerase-Specific Replication-Selective Virotherapy for Human Cancer
Kawashima, T., Kagawa, S., Kobayashi, N., Shirakiya, Y., Umeoka, T., Teraishi, F., Taki, M., Kyo, S., Tanaka, N., & Fujiwara, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1075-3 · Cited by 262
“We hypothesized that an adenovirus containing hTERT promoter-driven E1 genes could be used to target a variety of tumor cells and kill them efficiently by viral replication because 85% of human cancers display telomerase activity (6).”
BackgroundMitchell, J. R., & Collins, K. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00036-8 · Cited by 258
Kelland, L. R. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.11.024 · Cited by 252
Studies of the molecular mechanisms in the regulation of telomerase activity
LIU, J. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2091 · Cited by 254
“Removal or down-regulation of the RNA subunit leads to inhibition of telomerase, erosion of telomeres, compromise of growth capacity of highly proliferative embryonic stem cells (67), testicular cells, and hematopoietic cells (68) in the mouse, and death of both cultured HeLa cells (60) and malignant human glioma cell…”
BackgroundVeldman, T., Liu, X., Yuan, H., & Schlegel, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1435900100 · Cited by 214
Stable Association of hsp90 and p23, but Not hsp70, with Active Human Telomerase
Forsythe, H. L., Jarvis, J. L., Turner, J. W., Elmore, L. W., & Holt, S. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100055200 · Cited by 248
Anti-apoptotic Role of Telomerase in Pheochromocytoma Cells
Fu, W., Begley, J. G., Killen, M. W., & Mattson, M. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7264 · Cited by 248
Mushiroda, T., Wattanapokayakit, S., Takahashi, A., Nukiwa, T., Kudoh, S., Ogura, T., Taniguchi, H., Kubo, M., Kamatani, N., Nakamura, Y., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.057356 · Cited by 243
Three Ever Shorter Telomere ( EST ) genes are dispensable for in vitro yeast telomerase activity
Lingner, J., Cech, T. R., Hughes, T. R., & Lundblad, V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11190 · Cited by 237
Hrdlickova, B., de Almeida, R. C., Borek, Z., & Withoff, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.03.011 · Cited by 236
A novel telomerase template antagonist (GRN163) as a potential anticancer agent.
Asai, A., Oshima, Y., Yamamoto, Y., Uochi, T., Kusaka, H., Akinaga, S., Yamashita, Y., Pongracz, K., Pruzan, R., Wunder, E., et al. (2003) · PubMed · Cited by 291
Self-citationTelomerase Inhibition, Telomere Shortening, and Senescence of Cancer Cells by Tea Catechins
Naasani, I., Seimiya, H., & Tsuruo, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9075 · Cited by 238
The heterochromatin loss model of aging
Villeponteau, B. (1997) · Experimental Gerontology · doi:10.1016/s0531-5565(96)00155-6 · Cited by 237
Self-citationLudérus, M. E., van Steensel, B., Chong, L., Sibon, O. C., Cremers, F. F., & de Lange, T. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.4.867 · Cited by 232
Gowan, S. M., Heald, R., Stevens, M. F. G., & Kelland, L. R. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12507-2 · Cited by 230
“nents: an RNA template (hTR) (Feng et al., 1995); a catalytic”
Liu, K., Hodes, R. J., & Weng, N.-P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4826 · Cited by 234
“Studies of telomerase regulation in normal somatic cells have focused on expression of the two essential components of telomerase, telomerase RNA template (hTER) 2 (11) and telomerase reverse transcriptase (hTERT) (12, 13).”
BackgroundLiu, K., Schoonmaker, M. M., Levine, B. L., June, C. H., Hodes, R. J., & Weng, N.-P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5147 · Cited by 233
Role of telomerase in cellular proliferation and cancer
Holt, S. E., & Shay, J. W. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199907)180:1<10::aid-jcp2>3.0.co;2-d · Cited by 259
The catalytic subunit of yeast telomerase
Counter, C. M., Meyerson, M., Eaton, E. N., & Weinberg, R. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9202 · Cited by 228
McEachern, M. J., & Blackburn, E. H. (1996) · Genes & Development · doi:10.1101/gad.10.14.1822 · Cited by 224
Ouellette, M. M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.403 · Cited by 219
Massion, P. P., Kuo, W.-L., Stokoe, D., Olshen, A. B., TRESELER, P. A., Chin, K., Chen, C., Polikoff, D., Jain, A. N., Pinkel, D., et al. (2002) · PubMed · Cited by 222
Naming 'junk': Human non-protein coding RNA (ncRNA) gene nomenclature
Wright, M. W., & Bruford, E. A. (2011) · Human Genomics · doi:10.1186/1479-7364-5-2-90 · Cited by 213
Kanaya, T., Kyo, S., Hamada, K., Takakura, M., Kitagawa, Y., Harada, H., & Inoue, M. (2000) · PubMed · Cited by 280
Güneş, Ç., Lichtsteiner, S., Vasserot, A. P., & Englert, C. (2000) · PubMed · Cited by 241
Expression of mouse telomerase catalytic subunit in embryos and adult tissues
Martín-Rivera, L., Herrera, E., Albar, J. P., & Blasco, M. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10471 · Cited by 218
TRF1 binds a bipartite telomeric site with extreme spatial flexibility
Bianchi, A., Stansel, R. M., Fairall, L., Griffith, J. D., Rhodes, D., & de Lange, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5735 · Cited by 217
Telomerase Is Controlled by Protein Kinase Cα in Human Breast Cancer Cells
Li, H., Zhao, L., Yang, Z., Funder, J. W., & Liu, J.-P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33436 · Cited by 213
Telomerase Activity in Candidate Stem Cells From Fetal Liver and Adult Bone Marrow
Yui, J., Chiu, C.-P., & Lansdorp, P. M. (1998) · Blood · doi:10.1182/blood.v91.9.3255 · Cited by 216
Self-citationAn Alternate Splicing Variant of the Human Telomerase Catalytic Subunit Inhibits Telomerase Activity
Yi, X., White, D. M., Aisner, D. L., Baur, J. A., Wright, W. E., & Shay, J. W. (2000) · Neoplasia · doi:10.1038/sj.neo.7900113 · Cited by 214
The role of senescence and immortalization in carcinogenesis
Reddel, R. R. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.477 · Cited by 212
Vulliamy, T. J., Walne, A., Baskaradas, A., Mason, P. J., Marrone, A., & Dokal, I. (2005) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2004.12.008 · Cited by 211
Control of telomere length by a trimming mechanism that involves generation of t-circles
Pickett, H. A., Cesare, A. J., Johnston, R. L., Neumann, A. A., & Reddel, R. R. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.42 · Cited by 205
“…occurs as a result of end-replication limitations, the majority of immortal cells as well as cells of the germline use the ribonucleoprotein enzyme telomerase, the catalytic core of which comprises the reverse transcriptase hTERT and the RNA component hTR (Feng et al, 1995; Nakamura et al, 1997).”
BackgroundModulation of Life-span by Histone Deacetylase Genes in Saccharomyces cerevisiae
Kim, S., Benguria, A., Lai, C.-Y., & Jazwinski, S. M. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.10.3125 · Cited by 210
Renaud, S., Loukinov, D., Abdullaev, Z., Guilleret, I., Bosman, F. T., Lobanenkov, V., & Benhattar, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1125 · Cited by 204
“In vitro, two components are absolutely essential for telomerase activity: the catalytic subunit, hTERT, containing the reverse transcriptase activity, and the RNA component, hTERC, containing a complementary template for the telomeric DNA sequence (TTAGGG) (6,7).”
BackgroundHallmarks of telomeres in ageing research
Shay, J., & Wright, W. (2007) · The Journal of Pathology · doi:10.1002/path.2090 · Cited by 211
Zinn, R. L., Pruitt, K., Eguchi, S., Baylin, S. B., & Herman, J. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3396 · Cited by 210
“Expression of hTERT determines telomerase activity because hTR is ubiquitously expressed in most cells (13, 14 ).”
BackgroundTelomerase activity is detected in pancreatic cancer but not in benign tumors.
Hiyama, E., Kodama, T. S., Shinbara, K., Iwao, T., Itoh, M., Hiyama, K., Shay, J. W., Matsuura, Y., & Yokoyama, T. (1997) · PubMed · Cited by 224
hTERT associates with human telomeres and enhances genomic stability and DNA repair
Sharma, G. G., Gupta, A., Wang, H., Scherthan, H., Dhar, S., Gandhi, V., Iliakis, G., Shay, J. W., Young, C. S. H., & Pandita, T. K. (2003) · Oncogene · doi:10.1038/sj.onc.1206063 · Cited by 205
“The human telomerase holoenzyme contains a catalytic protein, hTERT and a 451-base integral RNA, hTR (Feng et al., 1995), that are essential for assembling telomerase activity in vitro and in vivo (Weinrich et al., 1997).”
BackgroundNaasani, I., Oh-hashi, F., Oh‐hara, T., Feng, W. Y., Johnston, J. S., Chan, K., & Tsuruo, T. (2003) · PubMed · Cited by 236
Role of Telomerase in Normal and Cancer Cells
Meyerson, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2626 · Cited by 204
RNA templating the epigenome: Long noncoding RNAs as molecular scaffolds
Spitale, R. C., Tsai, M.-C., & Chang, H. Y. (2011) · Epigenetics · doi:10.4161/epi.6.5.15221 · Cited by 193
“RNA can be found at the heart of complex machines such as the ribosome, RNaseP, telomerase and spliceosome.(9-12) Structural studies on these indispensable RNA-protein complexes have revealed a reoccurring theme: RNA can play a key scaffolding role that is critical for biological activity.”
BackgroundClinical utility of telomerase in cancer
Hiyama, E., & Hiyama, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205070 · Cited by 202
“Regulation of telomerase activity correlates with the expression of two major components: human telomerase RNA (hTR) (Feng et al., 1995) and human telomerase reverse transcriptase (hTERT) (Nakamura et al., 1997).”
BackgroundRapid induction of senescence in human cervical carcinoma cells
Goodwin, E. C., Yang, E., Lee, C.-J., Lee, H.-W., DiMaio, D., & Hwang, E.-S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10978 · Cited by 176
Telomerase RNA Accumulates in Cajal Bodies in Human Cancer Cells
Zhu, Y., Tomlinson, R. L., Lukowiak, A. A., Terns, R. M., & Terns, M. P. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-07-0525 · Cited by 193
“…tissues, telomerase activity is present in greater than 90% of Ͼ2000 malignant tumors examined (Shay and Bacchetti, 1997). hTERT is normally the limiting determinant of telomerase activity. hTR is present in both normal and cancer cells (Feng et al., 1995; Avilion et al., 1996; Yi et al., 1999).”
BackgroundProtein Phosphatase 2A Inhibits Nuclear Telomerase Activity in Human Breast Cancer Cells
Li, H., Zhao, L.-L., Funder, J. W., & Liu, J.-P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.16729 · Cited by 201
Architecture and assembly of mammalian H/ACA small nucleolar and telomerase ribonucleoproteins
Wang, C., & Meier, U. T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600181 · Cited by 199
“The DNA templates for the respective RNAs were constructed as follows: rat E3 and E2 snoRNAs were previously described (Wang et al, 2002); hTR under the T7 promoter was amplified from pGRN33 ( Feng et al, 1995; from Geron, Menlo Park, CA) using primers U250 and U251 (for primer sequences, see Supplementary Table I); r…”
MethodTelomerase regulation during entry into the cell cycle in normal human T cells.
Buchkovich, K. J., & Greider, C. W. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.9.1443 · Cited by 198
Self-citationGomes, N. M. V., Shay, J. W., & Wright, W. E. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.07.031 · Cited by 190
Hiyama, E., & Hiyama, K. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00709-7 · Cited by 179
Vascular smooth muscle cell senescence in atherosclerosis
GORENNE, I., KAVURMA, M., SCOTT, S., & BENNETT, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.06.004 · Cited by 196
“Telomeres are maintained by the enzyme telomerase, which contains an intrinsic RNA subunit (hTERC) and serves as a template for its catalytic subunit (hTERT) [46].”
Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells
Yi, X. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.23.4818 · Cited by 195
“hTR is present in all cell types (5,16), while hTERT mRNA is not detected in telomerase-negative cells (8,9).”
BackgroundGavathiotis, E., Heald, R. A., Stevens, M. F. G., & Searle, M. S. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.09.018 · Cited by 190
In vivo telomere dynamics of human hematopoietic stem cells
Notaro, R., Cimmino, A., Tabarini, D., Rotoli, B., & Luzzatto, L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13782 · Cited by 197
Harley, C. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205076 · Cited by 150
“The major concepts of this hypothesis were proven correct by speci®c manipulation of telomerase in human cells with the cloned components of the enzyme (Bodnar et al., 1998; Feng et al., 1995; Hahn et al., 1999; Nakamura et al., 1997; Vaziri and Benchimol, 1999; Zhang et al., 1999).”
BackgroundSelf-citationAlbanell, J., Engelhardt, M., Han, W., Moore, M. A. S., Lonardo, F., Rusch, V., Langenfeld, J., Klimstra, D., Venkatraman, E., & Dmitrovsky, E. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1609 · Cited by 193
Li, S., Rosenberg, J. E., Donjacour, A. A., Botchkina, I. L., Hom, Y. K., Cunha, G. R., & Blackburn, E. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0953 · Cited by 194
“The core essential components necessary for the reconstitution of human telomerase activity in vitro are the catalytic protein subunit, human telomerase reverse transcriptase (hTert), and the RNA subunit, hTER (12, 13).”
BackgroundPoly(A)-specific ribonuclease (PARN) mediates 3′-end maturation of the telomerase RNA component
Moon, D. H., Segal, M., Boyraz, B., Guinan, E., Hofmann, I., Cahan, P., Tai, A. K., & Agarwal, S. (2015) · Nature Genetics · doi:10.1038/ng.3423 · Cited by 183
Bryan, T. M., Marusic, L., Bacchetti, S., Namba, M., & Reddel, R. R. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.6.921 · Cited by 192
“Sequence of the first 598 bp of the hTR gene, showing changes from published sequence (31) in lower case bold.”
BackgroundBeyond microRNA – Novel RNAs derived from small non-coding RNA and their implication in cancer
Martens-Uzunova, E. S., Olvedy, M., & Jenster, G. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.11.058 · Cited by 188
Telomeres and senescence: The history, the experiment, the future
Greider, C. W. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70105-8 · Cited by 191
“Although telomerase is composed of both protein and RNA, the RNA component is often present even in cells that do not normally have activity [28].”
Self-citationInTERTpreting telomerase structure and function
Wyatt, H. D. M., West, S. C., & Beattie, T. L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq370 · Cited by 184
Senescence mechanisms of nucleus pulposus chondrocytes in human intervertebral discs
Kim, K.-W., Chung, H.-N., Ha, K.-Y., Lee, J.-S., & Kim, Y.-Y. (2009) · The Spine Journal · doi:10.1016/j.spinee.2009.04.018 · Cited by 188
Distinct Biogenesis Pathways for Human Telomerase RNA and H/ACA Small Nucleolar RNAs
Fu, D., & Collins, K. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00196-5 · Cited by 184
Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells
Cao, Y., Bryan, T. M., & Reddel, R. R. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00815.x · Cited by 182
Uhrbom, L., Hesselager, G., Östman, A., Nistér, M., & Westermark, B. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000201)85:3<407::aid-ijc18>3.0.co;2-8 · Cited by 85
Bièche, I., Noguès, C., Paradis, V., Olivi, M., Bédossa, P., Lidereau, R., & Vidaud, M. (2000) · PubMed · Cited by 204
Characteristics and Pathomechanisms of Endogenously Aged Skin
Makrantonaki, E., & Zouboulis, C. C. (2007) · Dermatology · doi:10.1159/000100890 · Cited by 176
Westerman, K. A., & Leboulch, P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.8971 · Cited by 183
Fu, W., Killen, M., Culmsee, C., Dhar, S., Pandita, T. K., & Mattson, M. P. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:14:1-2:003 · Cited by 186
“Suppression of such shortening is accomplished by telomerase, which adds a six-base DNArepeat sequence TTAGGG to the ends of chromosomes (Feng et al., 1995; Greider and Blackburn, 1996; Lingner et al., 1997).”
BackgroundWon, J., Yim, J., & Kim, T. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206064200 · Cited by 180
N-Terminal Domains of the Human Telomerase Catalytic Subunit Required for Enzyme Activity in Vivo
Armbruster, B. N., Banik, S. S. R., Guo, C., Smith, A. C., & Counter, C. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7775-7786.2001 · Cited by 183
“Human telomerase is a reverse transcriptase containing a 127-kDa catalytic protein (hTERT) (27, 32, 41, 47) that reverse transcribes the template region of the associated RNA subunit (hTR) (18) onto the 3 end of telomeric DNA, thereby elongating telomeres.”
BackgroundBiogenesis of telomerase ribonucleoproteins
Egan, E. D., & Collins, K. (2012) · RNA · doi:10.1261/rna.034629.112 · Cited by 177
“The mature 451-nt human TER, designated hTR in its original identification (Feng et al. 1995), is intermediate in length between ciliate and yeast TERs (Fig.”
BackgroundTelomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis
Newton, C. A., Zhang, D., Oldham, J. M., Kozlitina, J., Ma, S.-F., Martinez, F. J., Raghu, G., Noth, I., & Garcia, C. K. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1646oc · Cited by 173
“021 Compositex 6 (67) 3 (33) 3 (16) 3 (23) 0.”
BackgroundKyo, S., & Inoue, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205163 · Cited by 174
“…two major subunits contributing to enzymatic activity: a structural RNA component (hTER) that contains a template region that binds theTTAGGGrepeats in telomeres (Feng et al., 1995) and a catalytic subunit with reverse transcriptase activity (hTERT) (Meyerson et al., 1997; Nakamura et al., 1997).”
BackgroundTelomerase Activity Is Sufficient To Allow Transformed Cells To Escape from Crisis
Halvorsen, T. L., Leibowitz, G., & Levine, F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1864 · Cited by 182
“Conversely, immortal HeLa cells can be forced into crisis when the telomerase holoenzyme is disabled by the expression of antisense hTR (the RNA component of the enzyme) (19).”
BackgroundClinical implications of telomerase in cancer
Kim, N. W. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00057-9 · Cited by 180
Hypoxia Extends the Life Span of Vascular Smooth Muscle Cells through Telomerase Activation
Minamino, T., Mitsialis, S. A., & Kourembanas, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3336-3342.2001 · Cited by 178
“The mammalian telomerase RNA component (TERC) has been identified, and its expression was shown to correlate with cell proliferation as well as with telomerase activity in cancer cells (3).”
Yi, X., Tesmer, V. M., Savre-Train, I., Shay, J. W., & Wright, W. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.3989 · Cited by 175
“Telomerase is a ribonucleoprotein in which a catalytic reverse transcriptase protein subunit uses the RNA as a template for the addition of telomeric repeat sequences to the ends of chromosomes (11, 16, 17, 28, 34, 41).”
BackgroundMethodTelomerase and cancer: revisiting the telomere hypothesis
AUTEXIER, C., & GREIDER, C. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10042-6 · Cited by 165
Self-citationKyo, S., Nakamura, M., Kiyono, T., Maida, Y., Kanaya, T., Tanaka, M., Yatabe, N., & Inoue, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63583-3 · Cited by 174
Telomere maintenance mechanisms and cellular immortalization
Colgin, L. M., & Reddel, R. R. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80014-8 · Cited by 176
Ergin, A., Muntner, P., Sherwin, R., & He, J. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.03.017 · Cited by 173
The Catalytic Subunit of Telomerase Protects Neurons Against Amyloid β‐Peptide‐Induced Apoptosis
Zhu, H., Fu, W., & Mattson, M. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750117.x · Cited by 175
“…in somatic cells during maturation and aging, and such shortening is associated with a decrease in activity of an enzyme activity called telomerase that adds a six-base DNA repeat sequence (TTAGGG) to chromosome ends (Greider and Blackburn, 1989; Harley, 1991; Feng et al., 1995; Rhyu, 1995).”
BackgroundCardiac ageing: extrinsic and intrinsic factors in cellular renewal and senescence
Gude, N. A., Broughton, K. M., Firouzi, F., & Sussman, M. A. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0061-5 · Cited by 167
McMurray, H. R., & McCance, D. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.18.9852-9861.2003 · Cited by 143
“One hundred nanograms of Gal4-luc was cotransfected with 100 ng of vector or p300 (1-743)-Gal4 fusion protein and 100 ng of DN Myc.”
Method
Metadata
- Authors
- Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, Greider, C. W., & Villeponteau, B.
- Affiliations
- Geron (United States) (US)
- Cold Spring Harbor Laboratory (US)
- ORCID
- Venue
- Science
- Published
- 1995-09
- Volume
- 269
- Issue
- 5228
- Pages
- 1236-1241
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2026856852
- Cited by
- 2,227
- References
- 44
- Citations by year
- 2026: 10 · 2025: 23 · 2024: 20 · 2023: 36 · 2022: 35 · 2021: 33 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 44 · 2016: 74 · 2015: 54 · 2014: 47 · 2013: 62 · 2012: 61
- FWCI
- 54.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG09383)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- telomerase, hTR, telomeric repeats, antisense RNA, telomere shortening, HeLa cells
- MeSH terms
- Animals, Base Sequence, Cell Division, Cell Line, Cloning, Molecular, DNA Nucleotidylexotransferase, HeLa Cells, Humans, Molecular Sequence Data, RNA, Templates, Genetic, Transfection, Tumor Cells, Cultured, Polymerase Chain Reaction, Oligonucleotides, Antisense, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.